
Blake Aftab Ph.D.
@blake_aftab
Followers
215
Following
1K
Media
36
Statuses
498
Chief Scientific Officer @AdicetBio. #CART #TcellRx #TCR #gammadelta #immunotherapy ... Tweets are my own; retweets are not endorsements
California, USA
Joined September 2010
RT @srigsri23: Dear biologists, what would you be willing to pay for this service?👇. If you've got raw RNAseq data - can be 10 or can be a….
0
16
0
RT @AdicetBio: We are pleased to announce Shon Green, Ph.D, as our new Vice President of Nonclinical Development! Shon will play a crucial….
0
1
0
RT @BloodJournal: The latest issue of Blood is now available featuring a new review series on banked allogeneic immune effector cells. Also….
0
7
0
RT @khanna_rajiv: Please RT. Abstract submission for APVIC 2023 meeting is due by Feb 15. Don't forget register for the meeting as well. Yo….
0
9
0
RT @khanna_rajiv: Registration and abstract submission for Asia Pacific Vaccine and Immunotherapy Congress is open .
0
3
0
RT @AdicetBio: @AdicetBio announces positive clinical data including continued complete responses across dose levels and six-month durabili….
0
2
0
RT @ClinTransImmuno: Best of @ClinTransImmuno at #ASI2022Mel first up is @K_P_Nishimoto @AdicetBio describing their study published-.'Allog….
0
2
0
Couldn't be more proud of our scientists and our #team for what they are accomplishing with the strength of their science. #sitc2022.
Congratulations to Marissa Herrman & the Adicet research team for being selected as this year’s @jitcancer Best Immune Cell Therapies and Immune Cell Engineering Paper! Your commitment to developing transformative therapies to defeat cancer is inspiring! #celltherapy #SITC2022
0
0
1
RT @AdicetBio: Join us tomorrow (Thursday, Nov 10 at 9:00 a.m. ET) for our R&D Day where we’ll be unveiling details on four new highly diff….
0
1
0
RT @AdicetBio: Adicet is excited to be on the ground @sitcancer kicking off today in Boston! We’re presenting preclinical data and unveilin….
0
3
0
RT @BloodAdvances: Early use of third-party virus-specific T-cells is safe and leads to high rates of viral control and excellent outcomes….
0
6
0
RT @svbizjournal: Why $ACET is moving quickly with its cell therapy against non-Hodgkin's lymphoma — and taking more space #biotech https:….
0
1
0
RT @AdicetBio: As our pipeline progresses, we expanded into a new state-of-the-art facility! We look forward to calling this home as we liv….
0
2
0
RT @ChenSchor: Presence of gamma-delta1 T cells is strongly associated with survival of patients with Non-Small Cell Lung Cancer and severa….
0
1
0
RT @khanna_rajiv: Another reminder for upcoming ANZ ISCT meeting in Brisbane on Aug 4-5, 2022. Check this link for more details: https://t.….
0
7
0
RT @AdicetBio: We’re celebrating #pride at @Adicet and recognizing the important role the LGBTQ+ community has played in building diverse,….
0
2
0
RT @lindemilesphd: The Miles lab is hiring and our first job post is live!! We are looking for an excited, passionate research assistant to….
0
43
0
RT @NasdaqExchange: We're closing the day at the @NasdaqExchange with @AdicetBio! 🧬 . $ACET is a clinical stage biotechnology company disco….
0
4
0
RT @AdicetBio: On the heels of an exciting ASCO where we presented additional positive data on ADI-001, the team rang the closing bell at N….
0
1
0